Takeda surpasses analyst forecasts in Q1

Bloomberg reports that Takeda Pharmaceuticals surpassed analyst predictions in the first quarter of the year.
Lundbeck headquarters. | Photo: Lundbeck / PR
Lundbeck headquarters. | Photo: Lundbeck / PR
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

Takeda Pharmaceuticals, whose partner is Danish Lundbeck, surpassed analyst predictions in the first quarter, according to Bloomberg News.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading